DDR Combination Therapies Infographic
As the DDR space seeks to find efficacious combinations whilst minimising toxicity to patients, combination therapies are becoming a key topic of discussion. This infographic looks at current combination therapies being evaluated in the clinic by target, disease indication and more, with a particular focus on ATR inhibitors and DDRi’s in combination with ADC’s.
Infographic highlights include:
- An overview of the DDR combination therapy landscape
- A look at ATRi’s and ICM’S
- A focus on the emerging combination strategy of DDRi’s and ADC’S
- A summary of the current landscape and key learnings
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
